Biotechnology
Sanofi’s Strategic Acquisition of Principia Bears Fruit with Rilzabrutinib’s Phase III Success
Sanofi, Principia, acquisition, Rilzabrutinib, Phase III, clinical trial, success, strategic investment, pharmaceutical industry, biotechnology, drug development.
BMS Expands CAR-T Therapy Capabilities with Strategic $380 Million Investment in Cellares
BMS, Bristol Myers Squibb, Cellares, CAR-T therapy, cell therapy, cancer treatment, biotechnology, investment, capacity expansion, manufacturing, automation.
Pathios Secures $25M in Funding from BMS to Advance GPR65 Checkpoint Inhibitor Development
Pathios, Bristol-Myers Squibb (BMS), funding, GPR65, checkpoint inhibitor, cancer immunotherapy, drug development, biotechnology, investment.
AbbVie Secures Deal with Medincell for Long-Acting Injectable Platform, Valued up to $1.9 Billion
AbbVie, Medincell, Long-acting injectable platform, Biotechnology, Deal, $1.9 billion
Cullinan Secures $280M in Private Placement to Enter Autoimmune Market
Cullinan, Private Placement, $280M, Autoimmune Market, Biotechnology
Fujifilm Diosynth Announces $1.2B Expansion in North Carolina, Aiming to Employ 1,400
Fujifilm Diosynth Biotechnologies, $1.2 billion expansion, North Carolina, Holly Springs, 1/400 jobs, Biopharmaceutical manufacturing, End-to-end cell culture CDMO facility, Japanese investment